Phenix Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 13-12-2024
- Paid Up Capital ₹ 0.90 M
as on 13-12-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 13-12-2024
- Revenue 15.56%
(FY 2022)
- Profit 26.12%
(FY 2022)
- Ebitda 80.12%
(FY 2022)
- Net Worth 1.66%
(FY 2022)
- Total Assets 3.11%
(FY 2022)
About Phenix Bioscience
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹1.00 M.
Trupti Haval, Manohar Haval, and Anil Haval serve as directors at the Company.
- CIN/LLPIN
U51219PN2004PTC019748
- Company No.
019748
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Phenix Bioscience Private Limited offer?
Phenix Bioscience Private Limited offers a wide range of products and services, including Chisels & Professional Hand Tools, Hand Files & Planers, Industrial Chemicals & Supplies, Agro Chemicals, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Camera & Photography Equipments, Cinematographic Cameras, Fertilizers and Soil Additives, Fertilizer.
Who are the key members and board of directors at Phenix Bioscience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Trupti Haval  | Director | 17-Sep-2004 | Current |
| Manohar Haval | Director | 17-Sep-2004 | Current |
| Anil Haval | Director | 17-Sep-2004 | Current |
Financial Performance of Phenix Bioscience.
Phenix Bioscience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.56% increase. The company also saw a substantial improvement in profitability, with a 26.12% increase in profit. The company's net worth moved up by a moderate rise of 1.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phenix Bioscience?
In 2016, Phenix Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 01 Sep 2016 | ₹1.00 M | Open |
How Many Employees Work at Phenix Bioscience?
Unlock and access historical data on people associated with Phenix Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phenix Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phenix Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
